Skip to main content

Post-induction Minimal Residual Disease Defined by Next-Generation Sequencing Predicts Poorer Clinical Outcomes in Patients with Acute Myeloid Leukemiag

2022  USCAP (United States and Canadian Academy of Pathology 112th Annual Meeting)

March 19-24, 2022, Los Angeles, CA

Post-induction Minimal Residual Disease Defined by Next-Generation Sequencing Predicts Poorer Clinical Outcomes in Patients with Acute Myeloid Leukemiag

Authors: Li Y, Solis-Ruiz J, Tong CH,  Mohebnasab M,  Racke FK,  Lacbawan FL, Press R

Specialties: Oncology, Genetics